Jamal J. Hoballah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jamal J. Hoballah has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Rachad Wehbe
University of Rochester
5 shared publicationsFady Haddad
Division of Vascular Surgery, Department of Surgery, American University of Beirut, Beirut, Lebanon
4 shared publications- Mohamad A. Chahrour
Division of Vascular and Endovascular Surgery, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon
4 shared publications Rabih A. Houbballah
Henri Mondor Hospital
4 shared publicationsSung Woon Chung
Pusan National University Hospital
4 shared publications- Fady Haddad
Division of Vascular and Endovascular Surgery, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon
3 shared publications
Latest Publications
- Open Access
- 21 October 2025
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 12, 1672059
Endovascular management of splenic artery aneurysms in women of childbearing age: a case report and a review of literature
Introduction: Splenic artery aneurysms (SAAs), though rare, are the most common splanchnic artery aneurysms and carry high maternal and fetal mortality if ruptured during pregnancy. Despite growing awareness, optimal long-term management and follow-up in women of childbearing age remain unclear.Presentation of case: We report a case of a healthy 37-year-old gravida 2 para 2 woman with an incidentally discovered 1.4 cm mid-splenic artery aneurysm on follow-up imaging after gastric banding. Due to her reproductive potential, endovascular treatment was performed. Coil embolization of two small branches arising from the aneurysm sac was followed by placement of a balloon-mounted 7 mm covered stent across the aneurysm neck. The procedure was uncomplicated, and post-intervention imaging confirmed aneurysm exclusion and preserved distal flow. Follow-up at 3 and 6 months showed complete thrombosis of the sac, patent stent, and no evidence of infarction. Ten months later, the patient had an uneventful pregnancy and delivery.Discussion: Endovascular approaches are increasingly preferred over surgery due to lower morbidity and better fertility preservation. Coiling is effective but may risk recanalization or infarction. Covered stents offer structural stability, preserve splenic flow, and allow clearer imaging follow-up. However, challenges include delivery in tortuous vessels and a potential endoleak. In our case, combining coiling of branches with stenting ensured aneurysm exclusion while supporting safe pregnancy.Conclusion: Stent grafting with selective coiling is a safe and effective option for managing SAAs in women of childbearing age. This case demonstrates successful treatment with long-term follow-up through pregnancy, though further research is needed to establish definitive guidelines.
- 21 October 2025
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 12, 1672059
Open AccessEndovascular management of splenic artery aneurysms in women of childbearing age: a case report and a review of literature
Introduction: Splenic artery aneurysms (SAAs), though rare, are the most common splanchnic artery aneurysms and carry high maternal and fetal mortality if ruptured during pregnancy. Despite growing awareness, optimal long-term management and follow-up in women of childbearing age remain unclear.Presentation of case: We report a case of a healthy 37-year-old gravida 2 para 2 woman with an incidentally discovered 1.4 cm mid-splenic artery aneurysm on follow-up imaging after gastric banding. Due to her reproductive potential, endovascular treatment was performed. Coil embolization of two small branches arising from the aneurysm sac was followed by placement of a balloon-mounted 7 mm covered stent across the aneurysm neck. The procedure was uncomplicated, and post-intervention imaging confirmed aneurysm exclusion and preserved distal flow. Follow-up at 3 and 6 months showed complete thrombosis of the sac, patent stent, and no evidence of infarction. Ten months later, the patient had an uneventful pregnancy and delivery.Discussion: Endovascular approaches are increasingly preferred over surgery due to lower morbidity and better fertility preservation. Coiling is effective but may risk recanalization or infarction. Covered stents offer structural stability, preserve splenic flow, and allow clearer imaging follow-up. However, challenges include delivery in tortuous vessels and a potential endoleak. In our case, combining coiling of branches with stenting ensured aneurysm exclusion while supporting safe pregnancy.Conclusion: Stent grafting with selective coiling is a safe and effective option for managing SAAs in women of childbearing age. This case demonstrates successful treatment with long-term follow-up through pregnancy, though further research is needed to establish definitive guidelines.
- 1 October 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 130-142
Impact of Preoperative Chronic Steroid Use on Postoperative Outcomes following Open Surgical Repair of Unruptured Abdominal Aortic Aneurysm
- 1 October 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 130-142
Impact of Preoperative Chronic Steroid Use on Postoperative Outcomes following Open Surgical Repair of Unruptured Abdominal Aortic Aneurysm
- 6 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (6) , 2123-2132.e3
Popliteal-distal bypass versus infra-popliteal endovascular therapy for infra-popliteal occlusive disease
- 6 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (6) , 2123-2132.e3
Popliteal-distal bypass versus infra-popliteal endovascular therapy for infra-popliteal occlusive disease
- Open Access
- 18 July 2025
- Published by Springer Nature in Thrombosis Journal
- Vol. 23 (1) , 1-9
Utility of lower extremity ultrasound prior to application of serial compression device in patients with COVID-19: “choosing wisely” initiative at a major referral center in the Middle East
The link between venous thromboembolism (VTE) and coronavirus disease 2019 (COVID-19) infection has been consolidated by many studies in the literature. The increased risk of VTE among COVID-19 patients, on the one hand, and the morbidity that can be associated with the ICU course, on the other hand, promote quality care among this patient population. “Choosing wisely” is a quality improvement initiative that emphasizes the importance of assessing the utility of diagnostic tests. Our study was a “Choosing Wisely” single-center initiative aimed at assessing the utility of LEUS among COVID-19 patients who are treated at AUBMC, a major referral center in the Middle East. Data from hospitalized COVID-19 patients who underwent LEUS during the pandemic between 2019 and 2021 at our institution were retrospectively analyzed. LEUS was ordered to screen for preexisting DVT prior to the application of mechanical DVT prophylaxis via a serial compression device (SCD) or to rule out suspected DVT. Data on patients’ demographics, comorbidities, and mortality were also retrieved. A total of 179 patients were included in this study. The mean age of the patients was 66.09 ± 16.587 years, and 108 (60.3%) of our patients were men. Ninety-four (52.5%) patients underwent LEUS for asymptomatic DVT screening prior to SCD placement, and 84 (46.9%) patients underwent LEUS to rule out suspected DVT in the context of other causes, namely, prolonged hospital stay, immobilization, and other hypercoagulable risk factors. Among the 94 patients who underwent LEUS screening, 12 (12.76%) patients were found to have DVT, and SCD placement was consequently aborted. Half of these patients had an IVC filter placed afterward. A previous history of DVT or pulmonary embolism (PE) was strongly associated with DVT occurrence in ICU and non-ICU patients. The mortality rate was 88 (49.2%) among the studied population, which was the highest among the ICU patients (88 (69.8%) with p < 0.001). Compared with the available literature, we report a greater incidence of asymptomatic DVT among COVID-19 patients, including those screened prior to SCD. We suggest that the clinical utility of LEUS for this patient population outweighs its cost and presumed low benefit. Prospective studies with larger sample sizes are needed to further assess the utility of LEUS and promote the “Choosing Wisely” initiative.
- 18 July 2025
- Published by Springer Nature in Thrombosis Journal
- Vol. 23 (1) , 1-9
Open AccessUtility of lower extremity ultrasound prior to application of serial compression device in patients with COVID-19: “choosing wisely” initiative at a major referral center in the Middle East
The link between venous thromboembolism (VTE) and coronavirus disease 2019 (COVID-19) infection has been consolidated by many studies in the literature. The increased risk of VTE among COVID-19 patients, on the one hand, and the morbidity that can be associated with the ICU course, on the other hand, promote quality care among this patient population. “Choosing wisely” is a quality improvement initiative that emphasizes the importance of assessing the utility of diagnostic tests. Our study was a “Choosing Wisely” single-center initiative aimed at assessing the utility of LEUS among COVID-19 patients who are treated at AUBMC, a major referral center in the Middle East. Data from hospitalized COVID-19 patients who underwent LEUS during the pandemic between 2019 and 2021 at our institution were retrospectively analyzed. LEUS was ordered to screen for preexisting DVT prior to the application of mechanical DVT prophylaxis via a serial compression device (SCD) or to rule out suspected DVT. Data on patients’ demographics, comorbidities, and mortality were also retrieved. A total of 179 patients were included in this study. The mean age of the patients was 66.09 ± 16.587 years, and 108 (60.3%) of our patients were men. Ninety-four (52.5%) patients underwent LEUS for asymptomatic DVT screening prior to SCD placement, and 84 (46.9%) patients underwent LEUS to rule out suspected DVT in the context of other causes, namely, prolonged hospital stay, immobilization, and other hypercoagulable risk factors. Among the 94 patients who underwent LEUS screening, 12 (12.76%) patients were found to have DVT, and SCD placement was consequently aborted. Half of these patients had an IVC filter placed afterward. A previous history of DVT or pulmonary embolism (PE) was strongly associated with DVT occurrence in ICU and non-ICU patients. The mortality rate was 88 (49.2%) among the studied population, which was the highest among the ICU patients (88 (69.8%) with p < 0.001). Compared with the available literature, we report a greater incidence of asymptomatic DVT among COVID-19 patients, including those screened prior to SCD. We suggest that the clinical utility of LEUS for this patient population outweighs its cost and presumed low benefit. Prospective studies with larger sample sizes are needed to further assess the utility of LEUS and promote the “Choosing Wisely” initiative.
- 30 March 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 116, 55-60
Ankle Peak Systolic Velocity Correlates with Toe Pressure in Patients with Peripheral Artery Disease
- 30 March 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 116, 55-60
Ankle Peak Systolic Velocity Correlates with Toe Pressure in Patients with Peripheral Artery Disease
- 3 October 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 81 (1) , 173-181.e4
National trends and outcomes of pedal bypass surgery
- 3 October 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 81 (1) , 173-181.e4
National trends and outcomes of pedal bypass surgery
- Open Access
- 1 September 2023
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 9 (9) , e2300140
Biospecimen Repositories in Low- and Middle-Income Countries: Insights From an American University of Beirut and Memorial Sloan Kettering Collaboration
PURPOSE: Biobanking helps source tissue and blood for studying cancer genomics. Access to biorepository resources in low- and middle-income countries is lacking. Memorial Sloan Kettering Cancer Center (MSK) and the American University of Beirut (AUB) established a joint tissue biorepository at AUB in Beirut, Lebanon. The undertaking encountered key challenges that were unanticipated. MATERIALS AND METHODS: Patients age 18 years or older were eligible for enrollment at AUB. After consent, biospecimens were obtained at the time of routine diagnostic and/or therapeutic interventions. Both normal and abnormal tissue and solid and/or liquid specimens were collected from varied body sites. Early on, declining consent was frequently observed, and this was highlighted for investigation to understand potential participants reasoning. RESULTS: Of 850 patients approached, 704 (70.8%) elected to consent and 293 (29.5%) declined participation. The number of declined consents led to an amendment permitting the documentation of reasons for same. Of 100 potential participants who declined to consent and to whom outreach was undertaken, 63% indicated lack of research awareness and 27% deferral to their primary physician or family member. A financial gain for AUB was cited as concern by 5%, cultural boundaries in 4%, and 1% expressed concern about confidentiality. Of the patients who elected to consent, 682 biospecimens were procured. CONCLUSION: The AUB-MSK biospecimen repository has provided a unique resource for interrogation. Patient participation rate was high, and analyses of those who elected not to consent (29%) provide important insights into educational need and the local and cultural awareness and norms.
- 1 September 2023
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 9 (9) , e2300140
Open AccessBiospecimen Repositories in Low- and Middle-Income Countries: Insights From an American University of Beirut and Memorial Sloan Kettering Collaboration
PURPOSE: Biobanking helps source tissue and blood for studying cancer genomics. Access to biorepository resources in low- and middle-income countries is lacking. Memorial Sloan Kettering Cancer Center (MSK) and the American University of Beirut (AUB) established a joint tissue biorepository at AUB in Beirut, Lebanon. The undertaking encountered key challenges that were unanticipated. MATERIALS AND METHODS: Patients age 18 years or older were eligible for enrollment at AUB. After consent, biospecimens were obtained at the time of routine diagnostic and/or therapeutic interventions. Both normal and abnormal tissue and solid and/or liquid specimens were collected from varied body sites. Early on, declining consent was frequently observed, and this was highlighted for investigation to understand potential participants reasoning. RESULTS: Of 850 patients approached, 704 (70.8%) elected to consent and 293 (29.5%) declined participation. The number of declined consents led to an amendment permitting the documentation of reasons for same. Of 100 potential participants who declined to consent and to whom outreach was undertaken, 63% indicated lack of research awareness and 27% deferral to their primary physician or family member. A financial gain for AUB was cited as concern by 5%, cultural boundaries in 4%, and 1% expressed concern about confidentiality. Of the patients who elected to consent, 682 biospecimens were procured. CONCLUSION: The AUB-MSK biospecimen repository has provided a unique resource for interrogation. Patient participation rate was high, and analyses of those who elected not to consent (29%) provide important insights into educational need and the local and cultural awareness and norms.
- 30 May 2023
- Published by Springer Nature
- p. 101-114
Management of Pediatric Vascular Injuries in Blasts
- 30 May 2023
- Published by Springer Nature
- p. 101-114
Management of Pediatric Vascular Injuries in Blasts